减低强度异基因造血干细胞移植后的腺病毒血症和感染：我们应该建立一个常规筛查项目吗？ - Suppr

Suppr

超能文献

Adenovirus viremia and infection after reduced-intensity allogeneic hematopoietic stem cell transplant: should we institute a routine screening program?

作者信息

Soriano Gabriela, Perales Miguel-Angel

出版信息

Clin Infect Dis. 2012 Nov 15;55(10):1371-2. doi: 10.1093/cid/cis695. Epub 2012 Aug 16.

DOI:10.1093/cid/cis695

PMID:22903765

Abstract

摘要

相似文献

Adenovirus viremia and infection after reduced-intensity allogeneic hematopoietic stem cell transplant: should we institute a routine screening program?减低强度异基因造血干细胞移植后的腺病毒血症和感染：我们应该建立一个常规筛查项目吗？

Clin Infect Dis. 2012 Nov 15;55(10):1371-2. doi: 10.1093/cid/cis695. Epub 2012 Aug 16.

Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adults.在成人基于阿仑单抗的异基因干细胞移植后，腺病毒血症在大多数患者中具有有限的临床影响。

Clin Infect Dis. 2012 Nov 15;55(10):1362-70. doi: 10.1093/cid/cis689. Epub 2012 Aug 16.

Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation.基于风险的算法在监测异基因造血细胞移植后儿科受者巨细胞病毒、EB病毒和腺病毒感染中的风险因素及效用

Biol Blood Marrow Transplant. 2016 Sep;22(9):1646-1653. doi: 10.1016/j.bbmt.2016.05.014. Epub 2016 May 29.

In vivo T-cell depletion using alemtuzumab in family and unrelated donor transplantation for pediatric non-malignant disease achieves engraftment with low incidence of graft vs. host disease.在儿科非恶性疾病的亲属和非亲属供体移植中，使用阿仑单抗进行体内T细胞清除可实现植入，且移植物抗宿主病发生率较低。

Pediatr Transplant. 2015 Mar;19(2):211-8. doi: 10.1111/petr.12416. Epub 2014 Dec 26.

Risk factors for molecular detection of adenovirus in pediatric hematopoietic stem cell transplantation recipients.儿科造血干细胞移植受者腺病毒分子检测的危险因素。

Biol Blood Marrow Transplant. 2012 Aug;18(8):1227-34. doi: 10.1016/j.bbmt.2012.01.013. Epub 2012 Jan 25.

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab.

Biol Blood Marrow Transplant. 2004 Mar;10(3):186-94. doi: 10.1016/j.bbmt.2003.11.001.

Disseminated adenovirus infection after autologous stem cell transplant.自体干细胞移植后播散性腺病毒感染

Transpl Infect Dis. 2020 Feb;22(1):e13238. doi: 10.1111/tid.13238. Epub 2020 Jan 7.

Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management.

Leuk Lymphoma. 2004 May;45(5):873-85. doi: 10.1080/10428190310001628176.

Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact.成人CD34(+)选择造血细胞移植受者中的腺病毒血症：低发病率和高临床影响

Biol Blood Marrow Transplant. 2016 Jan;22(1):174-8. doi: 10.1016/j.bbmt.2015.08.019. Epub 2015 Aug 28.

Disseminated adenovirus disease by multiple adenovirus serotypes following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后由多种腺病毒血清型引起的播散性腺病毒疾病

Biol Blood Marrow Transplant. 2008 Mar;14(3):353-5. doi: 10.1016/j.bbmt.2007.12.001.

引用本文的文献

Adenovirus Viral Kinetics and Mortality in Ex Vivo T Cell-Depleted Hematopoietic Cell Transplant Recipients With Adenovirus Infection From a Single Center.腺病毒病毒动力学和单中心 T 细胞耗竭造血细胞移植受者腺病毒感染的死亡率。

J Infect Dis. 2020 Sep 1;222(7):1180-1187. doi: 10.1093/infdis/jiaa237.

Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: The AdVance study.欧洲异基因造血干细胞移植受者腺病毒感染管理的当前实践：AdVance 研究。

Eur J Haematol. 2019 Mar;102(3):210-217. doi: 10.1111/ejh.13194. Epub 2019 Jan 11.

Pre-Transplant Screening for Latent Adenovirus in Donors and Recipients.供体和受体潜在腺病毒的移植前筛查

Open Microbiol J. 2016 Feb 2;10:4-11. doi: 10.2174/1874285801610010004. eCollection 2016.

Biol Blood Marrow Transplant. 2016 Jan;22(1):174-8. doi: 10.1016/j.bbmt.2015.08.019. Epub 2015 Aug 28.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验